Mirati Therapeutics Inc (DELISTED) (MRTX:DL)
58.70
0.00 (0.00%)
USD |
NASDAQ |
Jan 23, 16:00
Mirati Therapeutics EPS Diluted (Quarterly): -2.49 for Sept. 30, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -2.49 |
| June 30, 2023 | -3.04 |
| March 31, 2023 | -3.18 |
| December 31, 2022 | -3.51 |
| September 30, 2022 | -3.09 |
| June 30, 2022 | -3.18 |
| March 31, 2022 | -3.40 |
| December 31, 2021 | -3.72 |
| September 30, 2021 | -1.55 |
| June 30, 2021 | -3.23 |
| March 31, 2021 | -2.67 |
| December 31, 2020 | -2.08 |
| September 30, 2020 | -1.96 |
| June 30, 2020 | -1.89 |
| March 31, 2020 | -2.02 |
| December 31, 2019 | -1.83 |
| September 30, 2019 | -1.38 |
| June 30, 2019 | -1.26 |
| March 31, 2019 | -1.17 |
| December 31, 2018 | -0.87 |
| September 30, 2018 | -0.85 |
| June 30, 2018 | -0.94 |
| March 31, 2018 | -0.51 |
| December 31, 2017 | -0.67 |
| September 30, 2017 | -0.65 |
| Date | Value |
|---|---|
| June 30, 2017 | -0.74 |
| March 31, 2017 | -0.73 |
| December 31, 2016 | -0.99 |
| September 30, 2016 | -0.97 |
| June 30, 2016 | -1.11 |
| March 31, 2016 | -1.13 |
| December 31, 2015 | -0.96 |
| September 30, 2015 | -1.11 |
| June 30, 2015 | -0.95 |
| March 31, 2015 | -0.77 |
| December 31, 2014 | -0.77 |
| September 30, 2014 | -0.72 |
| June 30, 2014 | -0.82 |
| March 31, 2014 | -1.01 |
| December 31, 2013 | -0.60 |
| September 30, 2013 | -2.95 |
| June 30, 2013 | -0.8046 |
| March 31, 2013 | -0.4235 |
| December 31, 2012 | -0.6334 |
| September 30, 2012 | -0.9343 |
| June 30, 2012 | -0.7356 |
| March 31, 2012 | -0.5278 |
| December 31, 2011 | -0.5705 |
| September 30, 2011 | -0.4818 |
| June 30, 2011 | -0.2581 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-3.72
Minimum
Dec 2021
-1.26
Maximum
Jun 2019
-2.527
Average
-2.58
Median
EPS Diluted (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | -5.89 |
| Karuna Therapeutics Inc (DELISTED) | -3.01 |
| Puma Biotechnology Inc | -0.10 |
| NovaBay Pharmaceuticals Inc | -5.25 |
| Palatin Technologies Inc | -0.53 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -161.90M |
| Revenue (Quarterly) | 16.40M |
| Total Expenses (Quarterly) | 188.45M |
| Gross Profit Margin (Quarterly) | 89.71% |
| Profit Margin (Quarterly) | -987.2% |